Literature DB >> 582109

[Determination and comparison of the plasma and urine concentrations in men given tranylcypromine stereoisomers].

A Lang, H E Geissler, E Mutschler.   

Abstract

The (+) and (-)isomers of DL-trans-2-phenylcyclopropylamine (tranylcypromine, Parnate, Jatrosom) were tested under cross-over conditions on 10 volunteers. (-)Tranylcypromine entered blood circulation more rapidly, reached significantly higher concentrations and was metabolized more slowly than (+)tranylcypromine. These results indicate a difference in the pharmacokinetics of the tranylcypromine isomers. In the urine collected over a period of 24 h the excretion of unmetabolized (4)tranylcypromine was lower probably resulting from the greater metabolization rate of this isomer. There is a conformity between the findings in plasma and urine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 582109

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

1.  Tranylcypromine isomers: single-dose effects in normal human subjects.

Authors:  C Gorenstein; V Gentil
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 2.  Metabolism of monoamine oxidase inhibitors.

Authors:  G B Baker; L J Urichuk; K F McKenna; S H Kennedy
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

3.  Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteers.

Authors:  P R Bieck; K H Antonin
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.

Authors:  R T Coutts; T S Rao; G B Baker; R G Micetich; T W Hall
Journal:  Cell Mol Neurobiol       Date:  1987-09       Impact factor: 5.046

5.  The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers.

Authors:  H Weber-Grandke; G Hahn; E Mutschler; W Möhrke; P Langguth; H Spahn-Langguth
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

6.  Tranylcypromine isomers and Parkinson's disease: new aspects of an old drug.

Authors:  G P Reynolds; P Riederer; M Sandler
Journal:  J R Soc Med       Date:  1981-09       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.